Don’t miss this unique opportunity to hear key insights from the 2025 Helix Summit, including sessions on innovative risk models, universal germline genetic testing in cardiology and oncology, and the transformative impact of pharmacogenetics.
The 6-part series below features key discussions from our 2025 Summit. You are invited to register for all or some of the weekly webinar sessions listed below.
Breaking the Diagnostic Odyssey
Learn how combining claims data, EHR insights, and genetics can help identify high-risk patients sooner, shorten diagnostic timelines, and reduce costs by improving care for individuals with likely genetic conditions.
Translating Insights into Real-World Adherence
Discover how targeted risk-reduction strategies after BRCA1/2 screening can significantly reduce breast cancer mortality, and learn how to close critical gaps in care through improved uptake.
Integrated Risk Models and Targeting Clinical Activities
Combining clinical and genetic risk factors creates more powerful predictive models. Learn about Helix’s new prediction models for GLP-1 response and disease progression in chronic kidney disease.
Unlocking the Potential of Pharmacogenetic Implementation
Explore the current landscape of pharmacogenomics and its practical implementation in healthcare, with evidence on drug labels, advancing scientific understanding, and demonstrable financial benefits.
Future-Focused Expansion of Universal Oncology Testing
Address the growing importance of universal germline testing in oncology and the challenges of its widespread adoption, and why many health systems still struggle with full-scale implementation.
Genetic Testing in Cardiovascular Medicine: A Call to Action
Highlight the transformative impact of genetic testing on cardiovascular care, emphasizing the urgent need for widespread integration to improve patient outcomes, risk stratification, and personalized treatment strategies.